Cargando…
Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage
The development and in vitro performance of a modular nanoscale system capable of specific structural modification by enzymatic activity is described in this work. Due to its small physical size and adaptable characteristics, this system has the potential for utilization in targeted delivery systems...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526364/ https://www.ncbi.nlm.nih.gov/pubmed/18488420 |
_version_ | 1782158739896270848 |
---|---|
author | Adam Smith, R Sewell, Sarah L Giorgio, Todd D |
author_facet | Adam Smith, R Sewell, Sarah L Giorgio, Todd D |
author_sort | Adam Smith, R |
collection | PubMed |
description | The development and in vitro performance of a modular nanoscale system capable of specific structural modification by enzymatic activity is described in this work. Due to its small physical size and adaptable characteristics, this system has the potential for utilization in targeted delivery systems and biosensing. Nanoparticle probes were synthesized containing two distinct fluorescent species including a quantum dot base particle and fluorescently labeled cleavable peptide substrate. Activity of these probes was monitored by gel electrophoresis with quantitative cleavage measurements made by fluorometric analysis. The model proximity-activated nanoparticles studied here exhibit significant susceptibility to cleavage by matrix metalloprotease-7 (MMP-7) at physiologically relevant concentrations, with nearly complete cleavage of available substrate molecules after 24 hours. This response is specific to MMP-7 enzyme activity, as cleavage is completely inhibited with the addition of EDTA. Utilization of enzyme-specific modification is a sensitive approach with broad applications for targeted therapeutics and biosensing. The versatility of this nanoparticle system is highlighted in its modular design, as it has the capability to integrate characteristics for detection, biosensing, targeting, and payload delivery into a single, multifunctional nanoparticle structure. |
format | Text |
id | pubmed-2526364 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2008 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-25263642008-09-04 Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage Adam Smith, R Sewell, Sarah L Giorgio, Todd D Int J Nanomedicine Original Research The development and in vitro performance of a modular nanoscale system capable of specific structural modification by enzymatic activity is described in this work. Due to its small physical size and adaptable characteristics, this system has the potential for utilization in targeted delivery systems and biosensing. Nanoparticle probes were synthesized containing two distinct fluorescent species including a quantum dot base particle and fluorescently labeled cleavable peptide substrate. Activity of these probes was monitored by gel electrophoresis with quantitative cleavage measurements made by fluorometric analysis. The model proximity-activated nanoparticles studied here exhibit significant susceptibility to cleavage by matrix metalloprotease-7 (MMP-7) at physiologically relevant concentrations, with nearly complete cleavage of available substrate molecules after 24 hours. This response is specific to MMP-7 enzyme activity, as cleavage is completely inhibited with the addition of EDTA. Utilization of enzyme-specific modification is a sensitive approach with broad applications for targeted therapeutics and biosensing. The versatility of this nanoparticle system is highlighted in its modular design, as it has the capability to integrate characteristics for detection, biosensing, targeting, and payload delivery into a single, multifunctional nanoparticle structure. Dove Medical Press 2008-03 2008-03 /pmc/articles/PMC2526364/ /pubmed/18488420 Text en © 2008 Smith et al, publisher and licensee Dove Medical Press Ltd. |
spellingShingle | Original Research Adam Smith, R Sewell, Sarah L Giorgio, Todd D Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage |
title | Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage |
title_full | Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage |
title_fullStr | Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage |
title_full_unstemmed | Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage |
title_short | Proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage |
title_sort | proximity-activated nanoparticles: in vitro performance of specific structural modification by enzymatic cleavage |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2526364/ https://www.ncbi.nlm.nih.gov/pubmed/18488420 |
work_keys_str_mv | AT adamsmithr proximityactivatednanoparticlesinvitroperformanceofspecificstructuralmodificationbyenzymaticcleavage AT sewellsarahl proximityactivatednanoparticlesinvitroperformanceofspecificstructuralmodificationbyenzymaticcleavage AT giorgiotoddd proximityactivatednanoparticlesinvitroperformanceofspecificstructuralmodificationbyenzymaticcleavage |